Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Sonic Hedgehog helps keep skin and airway barriers healthy and reduces inflammation.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Minoxidil dissolves better in ethanol-water mixtures at different temperatures, with water playing a key role.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Nonimmunosuppressive cyclosporines might treat skin diseases by affecting cell growth.

ILC1-like cells can independently cause alopecia areata.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

Folliculotropic mycosis fungoides can look like alopecia areata.

Plucked hair follicles can help diagnose scalp lupus.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

A patient with Sézary syndrome showed improvement after treatment and the study suggested follicular mucinosis might indicate future lymphoma risk.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

Follicular mycosis fungoides can look like a B-cell lymphoma, making diagnosis difficult.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Enhancing CD8+ T cell function to induce ferroptosis in tumor cells may help treat skin melanoma.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

HIV patients with lower CD4 T cell counts often have more skin problems.

A man with HIV developed skin and hair issues after starting HIV treatment, which improved with topical treatment.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

Corticosteroid injections helped eyebrow hair regrow in men with alopecia areata.